Mark D. Smith - 04 Dec 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Adam Guttmann, as attorney in fact For: Mark D. Smith
Issuer symbol
JAZZ
Transactions as of
04 Dec 2023
Transactions value $
-$49,736
Form type
4
Filing time
06 Dec 2023, 16:39:43 UTC
Previous filing
15 Aug 2023
Next filing
24 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Sale -$49.7K -417 -5.71% $119.27 6.89K 04 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.